Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$48.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Progress, Challenges, and Opportunities for Converting U.S. and Russian Research Reactors: A Workshop Future of the Nuclear Security Environment in 2015:Proceedings of a Russian-U.S. Workshop Other Related Titles Medical Isotope Production Without Highly Enriched Uranium (2009) Nuclear and Radiation Studies Board (NRSB) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix H: Acronyms." Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press, 2009. Please select a format: Page 200   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix H Acronyms ACCF American College of Cardiology Foundation ACRR Annular Core Research Reactor AECL Atomic Energy of Canada Limited AIPES Association of Imaging Producers and Equipment Suppliers ANL Argonne National Laboratory ANSTO Australian Nuclear Science and Technology Organisation ARI ANSTO Radiopharmaceuticals and Industrials ASNC American Society of Nuclear Cardiology ATR Advanced Test Reactor B&W Babcock & Wilcox BARC/BRIT Bhabha Atomic Research Centre/Board of Radiation and Isotope Technology BATAN Indonesian National Atomic Energy Agency BMS Bristol-Myers Squibb BR2 Belgian Reactor II CERCA Compagnie pour l’ Etude et la Réalisation de Combustibles Atomiques CFR Code of Federal Regulations CMR Chemistry and Metallurgy Research CMS Centers for Medicare & Medicaid Services CNEA Comisión Nactional de Energía Atómica CNSC Canadian Nuclear Safety Commission Page 200 Front Matter (R1-R18) Summary (1-6) 1 Background and Study Task (7-15) 2 Molybdenum-99/Technetium-99m Production and Use (16-30) 3 Molybdenum-99/Technetium-99m Supply (31-54) 4 Molybdenum-99/Technetium-99m Supply Reliability (55-65) 5 Molybdenum-99/Technetium-99m Demand (66-79) 6 Molybdenum-99/Technetium-99m Production Costs (80-89) 7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations (90-100) 8 Conversion to LEU-Based Production of Molybdenum-99: Regulatory Considerations (101-107) 9 Conversion to LEU-Based Production of Molybdenum-99: General Approaches and Timing (108-113) 10 Conversion to LEU-Based Production of Molybdenum-99: Prospects and Feasibility (114-141) 11 Progress in Eliminating HEU Use (142-162) References (163-168) Appendix A: Section 630 of the Energy Policy Act of 2005 (169-172) Appendix B: Biographical Sketches of Committee Members (173-180) Appendix C: Presentations and Visits (181-183) Appendix D: Alternative Molybdenum-99 Production Processes (184-189) Appendix E: Correspondence with Atomic Energy of Canada Limited (190-193) Appendix F: Present Value Calculation (194-195) Appendix G: Glossary (196-199) Appendix H: Acronyms (200-202)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 200
Medical Isotope Production without Highly Enriched Uranium Appendix H Acronyms ACCF American College of Cardiology Foundation ACRR Annular Core Research Reactor AECL Atomic Energy of Canada Limited AIPES Association of Imaging Producers and Equipment Suppliers ANL Argonne National Laboratory ANSTO Australian Nuclear Science and Technology Organisation ARI ANSTO Radiopharmaceuticals and Industrials ASNC American Society of Nuclear Cardiology ATR Advanced Test Reactor B&W Babcock & Wilcox BARC/BRIT Bhabha Atomic Research Centre/Board of Radiation and Isotope Technology BATAN Indonesian National Atomic Energy Agency BMS Bristol-Myers Squibb BR2 Belgian Reactor II CERCA Compagnie pour l’ Etude et la Réalisation de Combustibles Atomiques CFR Code of Federal Regulations CMR Chemistry and Metallurgy Research CMS Centers for Medicare & Medicaid Services CNEA Comisión Nactional de Energía Atómica CNSC Canadian Nuclear Safety Commission

OCR for page 201
Medical Isotope Production without Highly Enriched Uranium CORAR Council on Radionuclides and Radiopharmaceuticals CRADA Cooperative Research and Development Agreement CRP Coordinated Research Project CT Computed tomography DIF Dedicated Isotope Facilities DMF Drug Master File DOE U.S. Department of Energy DOE-NNSA U.S. Department of Energy, National Nuclear Security Administration DOS U.S. Department of State EOB End of bombardment EOI Expression of interest ESFRI European Strategy Forum on Research Infrastructures ETRR-2 Egyptian Testing Research Reactor II FDA U.S. Food and Drug Administration FDG 2-deoxy-2-[18F] fluoro-D-glucose (also called fluordeoxyglucose) FISS Fissile solution storage FRM-II Forschungsneutronenquelle Heinz Maier-Leibnitz (German: Research Reactor Munich II) FRRSNF Foreign Research Reactor Spent Nuclear Fuel GE General Electric GTCC Greater-than-class C GTRI Global Threat Reduction Initiative HEU Highly enriched uranium HFETR-C High Flux Engineering Test Reactor- China HFIR High Flux Isotope Reactor HFR High Flux Reactor HIFAR High Flux Australian Reactor HLW High-level waste IAEA International Atomic Energy Agency INFCE International Nuclear Fuel Cycle Evaluation INL Idaho National Laboratory INVAP Investigaciones Aplicadas Sociedad del Estado IRE Institut National des Radioéléments KAERI Korea Atomic Energy Research Institute

OCR for page 202
Medical Isotope Production without Highly Enriched Uranium LEU Low enriched uranium LLW Low-leve waste MDP Methylene diphosphonate MIPS Medical Isotope Production System MIT Massachusetts Institute of Technology MNSR Miniature Neutron Source Reactor MOU Memorandum of understanding MRI Magnetic resonance imaging MTR Materials Test Reactor MURR Missouri University Research Reactor NBSR National Bureau of Standards Reactor NDA New Drug Application NECSA Nuclear Energy Corporation of South Africa NNSA National Nuclear Security Administration NPF New processing facility NRG Nuclear Research and Consultancy Group NRU National Research Universal (reactor) NTP Nuclear Technology Products OPAL Open Pool Australian Lightwater (reactor) OWR Omega West Reactor PET Positron emission tomography POLATOM Institute of Atomic Energy Radioisotope Centre R&D Research and development RERTR Reduced Enrichment for Research and Test Reactors RF Russian Federation RRRFR Russian Research Reactor Fuel Return sNDA Supplemental New Drug Application SPECT Single photon emission computed tomography SRS Savannah River site TCI Technology Commercialization International USNRC U.S. Nuclear Regulatory Commission USP United States Pharmacopeia